Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 34

    1.

    A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol.

    Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ.

    J Biol Chem. 2002 Mar 29;277(13):10795-803. Epub 2002 Jan 14.PMID: 11790780 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The cellular metabolism and systemic toxicity of arsenic.

    Thomas DJ, Styblo M, Lin S.

    Toxicol Appl Pharmacol. 2001 Oct 15;176(2):127-44. Review.PMID: 11601889 [PubMed - indexed for MEDLINE]Related articles

    3.

    Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily.

    Zakharyan RA, Sampayo-Reyes A, Healy SM, Tsaprailis G, Board PG, Liebler DC, Aposhian HV.

    Chem Res Toxicol. 2001 Aug;14(8):1051-7.PMID: 11511179 [PubMed - indexed for MEDLINE]Related articles

    4.

    Determination of trivalent methylated arsenicals in biological matrices.

    Del Razo LM, Styblo M, Cullen WR, Thomas DJ.

    Toxicol Appl Pharmacol. 2001 Aug 1;174(3):282-93.PMID: 11485389 [PubMed - indexed for MEDLINE]Related articles

    5.

    Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase.

    Petrick JS, Jagadish B, Mash EA, Aposhian HV.

    Chem Res Toxicol. 2001 Jun;14(6):651-6.PMID: 11409934 [PubMed - indexed for MEDLINE]Related articles

    6.

    Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.

    Kitchin KT.

    Toxicol Appl Pharmacol. 2001 May 1;172(3):249-61. Review.PMID: 11312654 [PubMed - indexed for MEDLINE]Related articles

    7.

    Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.

    Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D.

    Toxicol Appl Pharmacol. 2001 May 1;172(3):225-32.PMID: 11312651 [PubMed - indexed for MEDLINE]Related articles

    8.

    Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India.

    Mandal BK, Ogra Y, Suzuki KT.

    Chem Res Toxicol. 2001 Apr;14(4):371-8.PMID: 11304125 [PubMed - indexed for MEDLINE]Related articles

    9.

    Methylated trivalent arsenic species are genotoxic.

    Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ, Kligerman AD.

    Chem Res Toxicol. 2001 Apr;14(4):355-61.PMID: 11304123 [PubMed - indexed for MEDLINE]Related articles

    10.

    Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine.

    Le XC, Ma M, Cullen WR, Aposhian HV, Lu X, Zheng B.

    Environ Health Perspect. 2000 Nov;108(11):1015-8.PMID: 11102289 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Speciation of key arsenic metabolic intermediates in human urine.

    Le XC, Lu X, Ma M, Cullen WR, Aposhian HV, Zheng B.

    Anal Chem. 2000 Nov 1;72(21):5172-7.PMID: 11080860 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells.

    Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ.

    Arch Toxicol. 2000 Aug;74(6):289-99.PMID: 11005674 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?

    Simeonova PP, Luster MI.

    J Environ Pathol Toxicol Oncol. 2000;19(3):281-6. Review.PMID: 10983894 [PubMed - indexed for MEDLINE]Related articles

    14.

    Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic.

    Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D, Aposhian MM.

    Chem Res Toxicol. 2000 Aug;13(8):693-7.PMID: 10956055 [PubMed - indexed for MEDLINE]Related articles

    15.

    Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation.

    Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, Luster MI.

    Cancer Res. 2000 Jul 1;60(13):3445-53.PMID: 10910055 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes.

    Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Vasken Aposhian H.

    Toxicol Appl Pharmacol. 2000 Mar 1;163(2):203-7.PMID: 10698679 [PubMed - indexed for MEDLINE]Related articles

    17.

    Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase.

    Radabaugh TR, Aposhian HV.

    Chem Res Toxicol. 2000 Jan;13(1):26-30.PMID: 10649963 [PubMed - indexed for MEDLINE]Related articles

    18.

    Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase.

    Zakharyan RA, Aposhian HV.

    Chem Res Toxicol. 1999 Dec;12(12):1278-83.PMID: 10604879 [PubMed - indexed for MEDLINE]Related articles

    19.

    Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase.

    Lin S, Cullen WR, Thomas DJ.

    Chem Res Toxicol. 1999 Oct;12(10):924-30.PMID: 10525267 [PubMed - indexed for MEDLINE]Related articles

    20.

    Induction of p53 protein expression by sodium arsenite.

    Salazar AM, Ostrosky-Wegman P, Menéndez D, Miranda E, García-Carrancá A, Rojas E.

    Mutat Res. 1997 Nov 28;381(2):259-65.PMID: 9434882 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data